Heavy Heart: The Economic Burden of Heart Disease in the United States Now and in the Future
- PMID: 29406942
- DOI: 10.1016/j.pop.2017.11.002
Heavy Heart: The Economic Burden of Heart Disease in the United States Now and in the Future
Abstract
The United States spends more on health care than any other industrialized nation. In 2016, health care expenditure reached an estimated $3.35 trillion or $10,345 per individual. Cardiovascular disease represents the leading cause of death and disability as well as the most significant source of health care spending. This article reviews the current economic burden of heart disease in the United States, presents future projections, and explores factors driving cost growth in cardiovascular care.
Keywords: Cardiovascular care; Health care costs; Health economics; Overuse.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Projected Costs of Informal Caregiving for Cardiovascular Disease: 2015 to 2035: A Policy Statement From the American Heart Association.Circulation. 2018 May 8;137(19):e558-e577. doi: 10.1161/CIR.0000000000000570. Epub 2018 Apr 9. Circulation. 2018. PMID: 29632217 Review.
-
The economic burden of chronic cardiovascular disease for major insurers.Health Promot Pract. 2007 Jul;8(3):234-42. doi: 10.1177/1524839907303794. Health Promot Pract. 2007. PMID: 17606951
-
Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association.Circulation. 2024 Jul 23;150(4):e89-e101. doi: 10.1161/CIR.0000000000001258. Epub 2024 Jun 4. Circulation. 2024. PMID: 38832515 Review.
-
The future of cardiology: utilization and costs of care.J Am Coll Cardiol. 2000 Apr;35(5 Suppl B):91B-98B. J Am Coll Cardiol. 2000. PMID: 10757374 No abstract available.
-
The future of cardiology: utilization and costs of care.J Am Coll Cardiol. 2000 Mar 15;35(4):1092-9. doi: 10.1016/s0735-1097(00)00559-3. J Am Coll Cardiol. 2000. PMID: 10732913 No abstract available.
Cited by
-
Risk of Cardiovascular Disease After COVID-19 Diagnosis Among Adults With and Without Diabetes.J Am Heart Assoc. 2023 Jul 4;12(13):e029696. doi: 10.1161/JAHA.123.029696. Epub 2023 Jun 29. J Am Heart Assoc. 2023. PMID: 37382101 Free PMC article.
-
What We Talk About When We Talk About Troponin: A Descriptive Study of Troponin Terms.Brown J Hosp Med. 2022 Jul 18;1(3):37011. doi: 10.56305/001c.37011. eCollection 2022. Brown J Hosp Med. 2022. PMID: 40046579 Free PMC article.
-
Impact of Yoga beyond Physical Training on the Cardiovascular System: An Updated Review.J Tehran Heart Cent. 2024 Apr;19(2):79-88. doi: 10.18502/jthc.v19i2.16195. J Tehran Heart Cent. 2024. PMID: 40322769 Free PMC article. Review.
-
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic Sarcoidosis.Clinicoecon Outcomes Res. 2023 Oct 17;15:739-752. doi: 10.2147/CEOR.S428466. eCollection 2023. Clinicoecon Outcomes Res. 2023. PMID: 37868649 Free PMC article.
-
Later circadian timing and increased sleep timing variability are associated with attenuations in overnight blood pressure dipping among chronic nightshift workers.Sleep Health. 2024 Feb;10(1S):S140-S143. doi: 10.1016/j.sleh.2023.08.010. Epub 2023 Sep 22. Sleep Health. 2024. PMID: 37741702 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical